November 20, 2026

Beyond Net-Nets: Why I Added Quality and Momentum to Deep Value

I built this screener because I love Ben Graham's net-net idea. But after years of running it with real money and honest backtests, I learned where it breaks down in today's markets. This is what I found, and what I do differently now.

Net-net investing is one of the most elegant ideas in finance. Buy a company for less than its net current assets, wait for the market to notice, sell. No forecasts, no stories, just the balance sheet. It is also how I got serious about rules-based investing, and I still think every value investor should understand it.

But an idea that works on paper has to survive three things in practice: enough opportunities, enough liquidity, and realistic trading costs. That is where classic net-nets have become hard to use for most investors today.


Problem 1: There Are Very Few of Them

In Graham's day, after the crash of the 1930s, net-nets were everywhere. In the United States, Canada and Europe today, a strict screen for stocks below two-thirds of NCAV often returns only a handful of names. Graham recommended holding 20 to 30 net-nets to diversify away the inevitable failures. When the screen only gives you a few candidates, you either hold a concentrated portfolio of troubled companies, or you lower your standards until the strategy is no longer the one that was backtested.

Many investors respond by moving to Japan or other Asian markets, where net-nets are more common. That can work, but it adds currency risk, language barriers, broker restrictions and a different question: do these stocks ever re-rate, or do they stay cheap forever?

Problem 2: Many of Them Barely Trade

The companies that make it through a net-net screen are usually tiny. Many trade only a few thousand dollars a day. That has two consequences that a simple backtest hides:

  • You move the price. Buying a meaningful position pushes the price up, selling pushes it down. The cheap price in the backtest is often not the price you actually get.
  • The spread eats the return. Bid-ask spreads of several percent are common. Pay that on the way in and on the way out, every time the portfolio turns over, and a large part of the edge is gone.

Problem 3: The Backtest Looks Better Than Reality

This is the lesson that changed my mind. When I re-ran my own net-net backtests with realistic slippage and transaction costs, the picture changed. There were still periods of strong returns, but relative to a simple benchmark the results were far less convincing than the cost-free version suggested. Annual turnover was above 100%, so the costs hit the portfolio more than once a year.

A simple test for any strategy

Ask whether the backtest includes slippage and trading costs, and whether the stocks are liquid enough to actually buy. If not, treat the headline return as an upper bound, not a forecast.

There is also a fourth, quieter problem: quality. Many stocks trade below liquidation value because something is genuinely wrong. Cash is burning, the business is shrinking, management is not acting in shareholders' interest. Cheapness alone cannot tell a hidden gem from a value trap.


What I Do Differently Now

The answer was not to abandon value, but to stop relying on value alone. Instead of asking only "is it cheap?", I now ask several independent questions about every small cap, and only buy the stocks that score well across all of them:

  • Quality (30%): Is the business profitable, cash-generative and financially sound?
  • Value (25%): Is it cheap relative to earnings, cash flow and assets?
  • Growth (15%): Are sales and earnings moving in the right direction?
  • Low volatility (10%): Is the stock calmer than its peers?
  • Sentiment (10%): Are estimates and expectations improving?
  • Momentum (10%): Has the market started to notice?

Value still carries a quarter of the weight, so the deep value DNA is still there. But a cheap stock now also has to be a decent business, and ideally one the market is beginning to re-rate. That last point addresses the oldest net-net frustration: buying something cheap and waiting years for a catalyst that never comes.

Just as important are the practical rules. The universe is small and micro caps in Europe, Canada and the USA with a market cap between $10 million and $2 billion and at least $30,000 traded per day. That liquidity filter alone removes most of the stocks that look great in a backtest but can't be traded in real life.

The Process in Three Steps

  1. Buy the top: Rank every eligible stock and hold the ~20 best-ranked names, equally weighted.
  2. Hold while the rank stays at 95 or above. The ranking is checked every week.
  3. Sell below 95 and replace the stock with the best-ranked name you don't own yet.

No forecasts, no stories, no overrides. The same discipline that makes net-nets attractive, applied to a much larger and more liquid universe.

The Results, Including the Bad Years

In a simulation from January 2009 to November 2026, including slippage and transaction costs, this approach returned about 22.5% per year, compared with 14.6% for the S&P 500. With an annual turnover of around 75%, the average position is held for more than a year.

It was not a straight line. The strategy lost money in 2018 and 2022, trailed the S&P 500 in several years, and went through a maximum drawdown of about 34%, roughly the same as the index. I think that is exactly what you should expect from an honest small-cap strategy, and knowing it in advance makes it much easier to stay disciplined when it happens. You can see the full backtest, year by year.


Where Net-Nets Still Fit

I still find net-nets fascinating, and the NCAV framework remains one of the best ways to understand what a business is really worth on a bad day. Net Net Screener is a good tool for exploring that corner of the market and for learning to read balance sheets.

But if you want a repeatable process you can run with real money, in stocks you can actually trade, I believe a multi-factor approach is the better foundation. That is why I built a second tool for it.

The Small Edge

A daily-updated ranking of small caps in Europe, Canada and the USA, with clear sell signals and a personal portfolio tracker, built on exactly the rules described above.

See how The Small Edge picks small caps by rules, not by stories →

Michael Rehermann. Backtest results are simulated and not indicative of future returns. For informational purposes only, not investment advice.